2m 2m 2m 2m 2m 2m 2m
TAYSHA GENE THER (TSHA)
NASDAQ
$6.08-$0.01 (-0.21%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.0BMarket Cap
- 103.00%1-Year Change
- BiotechnologyIndustry
TAYSHA GENE THER (TSHA)
$6.08-$0.01 (-0.21%)
TSHA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.09 | ||
Change | -$0.02 (-0.33%) | ||
Open | $6.18 | ||
High | $6.24 | ||
Low | $6.01 | ||
Previous Close | $6.11 | ||
Volume | 2,831,061 | ||
30-Day Average Volume | 2,708,911 | ||
1-Week Change | 2.35% | ||
1-Month Change | 7.41% | ||
1-Year Change | 103.00% | ||
3-Year Change | 217.19% | ||
5-Year Change | -64.03% | ||
Fundamentals | |||
Shares Outstanding | 325.8M | ||
Total Assets | $470.4M | ||
Market Cap | $2.0B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$46.6M | ||
Free Cash Flow | -$40.4M | ||
EBIT | -$46.6M | ||
EBITDA | -$46.3M | ||
Net Working Capital | $435.5M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -47 | ||
PEG | 6 | ||
Price/Free Cash Flow | -49 | ||
Price/Operating Cash Flow | -49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue